Core Scientific Shares Fall as Q4 Revenue Misses Estimates, Adjusted EBITDA Turns Negative
CORZ has more than doubled off its 52-week low of $6.2.
Summary
Core Scientific reported fourth-quarter earnings that missed analyst revenue expectations, posting $79.8 million against an anticipated $90.4 million, and recorded an adjusted EBITDA loss of $42.7 million. This news follows the company's Q4 results announcement and an earlier headline highlighting a significant net income, but this report focuses on the operational miss and negative market reaction. The revenue decline, particularly a nearly 50% drop in crypto mining revenue, is a material concern for the company, especially in light of recent restatements and an adverse auditor opinion on internal controls. Traders will be closely watching the company's strategic pivot to AI colocation services and its ability to improve core profitability amidst challenging market conditions.
At the time of this announcement, CORZ was trading at $16.50 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $6.20 to $23.63. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Cointelegraph.